🇺🇸 FDA
Patent

US 10688174

Method of conferring a protective immune response to norovirus

granted A61KA61K2039/5258A61K2039/543

Quick answer

US patent 10688174 (Method of conferring a protective immune response to norovirus) held by Takeda Vaccines, Inc. expires Mon Jun 18 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Vaccines, Inc.
Grant date
Tue Jun 23 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 18 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K2039/5258, A61K2039/543, A61K2039/55572, A61K2039/55583